Clinical Trial Update: A Drug Interaction Study With Fluticasone Furoate/GW642444 Inhalation Powder and Ketoconazole [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the drug interaction between Fluticasone Furoate/GW642444 Inhalation Powder and ketoconazole in asthma patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Fluticasone Furoate/GW642444 Inhalation Powder
• Ketoconazole (Ketoconazole)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 1 | Status: COMPLETED